Casper K Nielsen
Overview
Explore the profile of Casper K Nielsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
9
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nicolaisen T, Lyster A, Sjoberg K, Haas D, Voldstedlund C, Lundsgaard A, et al.
Nat Metab
. 2025 Mar;
PMID: 40050437
Dietary protein restriction increases energy expenditure and enhances insulin sensitivity in mice. However, the effects of a eucaloric protein-restricted diet in healthy humans remain unexplored. Here, we show in lean,...
2.
Palsson T, Gilliam-Vigh H, Jensen B, Jeppesen P, Lund A, Knop F, et al.
Peptides
. 2024 Apr;
177:171210.
PMID: 38579917
Recent advancements in understanding glucagon-like peptide 2 (GLP-2) biology and pharmacology have sparked interest in targeting the GLP-2 receptor (GLP-2R) in the treatment of obesity. GLP-2 is a proglucagon-derived 33-amino...
3.
Nielsen C, Ohrstrom C, Houji I, Helsted M, Krogh L, Johansen N, et al.
Diabetes Care
. 2023 Oct;
46(12):2208-2217.
PMID: 37819999
Objective: Postbariatric hypoglycemia affects >50% of individuals who have undergone Roux-en-Y gastric bypass surgery. Despite the often debilitating nature of this complication, existing treatment options are limited and often inefficient....
4.
Helsted M, Gasbjerg L, Vilsboll T, Nielsen C, Forman J, Christensen M, et al.
BMJ Open
. 2023 Feb;
13(2):e065736.
PMID: 36849212
Introduction: Due to reports of severely reduced insulinotropic effect of the incretin hormone glucose-dependent insulinotropic polypeptide (GIP) in type 2 diabetes (T2D), GIP has not been considered therapeutically viable. Recently,...
5.
Nielsen C, Ohrstrom C, Kielgast U, Hansen D, Hartmann B, Holst J, et al.
Diabetes Care
. 2022 Mar;
45(6):1476-1481.
PMID: 35320361
Objective: To investigate the efficacy and safety of dasiglucagon, a novel stable glucagon analog in a liquid formulation, in Roux-en-Y gastric bypass (RYGB)-operated individuals suffering from postbariatric hypoglycemia (PBH). Research...